ALIS ALIS
Company Profile ↓Company Overview
ALIS (ALIS) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 48.8%, reflecting efficient use of shareholder capital.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +2.53% |
| 6 Months: | +1.70% |
| 3 Months: | +0.99% |
| 1 Month: | +0.10% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- RSI (14)54.17 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 48.8%.
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2024 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Operating Income | -20.60K | -61.80K | -588.02K |
| Net Income | -20.60K | -61.78K | -53.29K |
| Diluted EPS | -0.01 | -0.03 | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2025 |
|---|---|
| Operating Income | -190.58K |
| Net Income | 245.45K |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Total Assets | 220.63K | 61.02M |
| Total Equity | 73.58K | 503.04K |
| Cash & Equivalents | 1.49K | 459.05K |
| Total Liabilities | 147.06K | 85.19K |
| Current Liabilities | 147.06K | 85.19K |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2025 |
|---|---|
| Operating Cash Flow | -286.50K |
| Investing Cash Flow | -60.00M |
| Financing Cash Flow | 60.74M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2025 |
|---|---|
| Gross Margin % | - |
| Operating Margin % | - |
| Net Margin % | - |
| ROE % | 48.8% |
| ROCE % | -0.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ALIS
Calisa Acquisition Corp (NASDAQ: ALIS) agrees to $8M share sale for Goodvision deal - Stock Titan
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxNNm82UzNWTG8tQWZuSGxvb3g5VVdRWi1veV9lV2pncFZVemYzazg3OGRRRkFfVW84OThZNnBxLVBNQ3BSdV9hdVBvRXBfN3NUblp1cnJrdkthZzNyWjR2TGtQWEl5VkdpRzVRUHdFSmNSdnZlRVJvR3MtWGl6enl5SHF4dHpPakhjamFNSV…
Calisa Acquisition Corp Revenue Breakdown – NASDAQ:ALIS - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFBwenpCY0hVUnJDWktVYWFHekdkWmdyWW9zSHpreEh1dTZXUDJGbEFnb1gzbm5FUDAzRHBlQWJvZFJlTjJvanJWUzVWYWRER2pMSWFDNlVweW9WQ2NqWWNpUVJVWWI0LXdCQ0RQODA2bG1nTXoxYlY4?oc=5" target="_blank">Calisa …
ALIS Plus Multidrug Therapy Improves Symptoms, Culture Conversion in Newly Diagnosed MAC Lung Disease - The American Journal of Managed Care
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxNa3pxaGp5cl85Zll6Z3BfZFlrb3Q4bF9SWjRvanE2MlUwdkI2MTlOTXE5QklnRDExRDU4QlZDZF9YV2tPaHdqTmdUdWpsbEpGZU4xSTBpTTlCcTlRTW9QeTVSLTYxanpROUNLd2hGS2w0eDY5ZGZfeEVnU2R6NUtCbFIzQTRXT2p3WDZzWT…
ALIS|Calisa Acquisition Ord Shs|Price:10.165| - TradingKey
<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE5SRGxNVk1veExNVVBJSzdURGo5WjlUMHNZRG5IeHRrY3pfLTVMMHRaNFp1M3NMczRSSlMwR1FVNTFZSDBVeTBNd0xuVzdPVUpHUDAzbFVFMjM3UQ?oc=5" target="_blank">ALIS|Calisa Acquisition Ord Shs|Price:10.165|…
Calisa Acquisition Corp (NASDAQ: ALIS) furnishes Goodvision AI merger presentation - Stock Titan
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxNejhUZWZka2VRNGVhb0gtUC14aGlfUGlfQXg3Y0ZPeWdocXFkT0haTkNTelEtNUM5bjBCa1JVSDFwQzRqWlRibXpYelJTV0xZVlctQ3pDMVNPamFPSjZkY20yMnFIZFFvMVFBUnlGLV9seHZvamFWNTdIXzJDQXZCLVd3MzNUaEF3M25fTV…
Calisa Acquisition Corp Rings the Closing Bell - Nasdaq
<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTFBYZXo0ZDd2TEtzeFdaRnlYaUtDUjJlOGFHLXVydEtYbnBWbEwxWmIxbmJrQ21CTVlYcDBCeHZWcmdSVVZIVGlMblp4cGh5SFZRZDlKNWxYVGxYeW5aUjFoN0RWQlRFbVBlOEEwcFpyOGFKT2Q2V3BGR29WRVQ?oc=5" target="_blank">…
ALIS — Frequently Asked Questions
What is the current share price of ALIS?
As of 2026-08-05 17:25 PDT, ALIS trades at $10.17 on NASDAQ/NYSE. Its 52-week range is $9.90 to $10.19.
What is the return on equity (ROE) of ALIS?
ALIS has a return on equity (ROE) of 48.79%. Its return on capital employed (ROCE) is -0.31%.
Is ALIS a good stock to buy?
This page provides a data-driven analysis of ALIS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.